Gas6/Axl signaling pathway promotes proliferation, migration and invasion and inhibits apoptosis in A549 cells

Wang,Dong; Bi,Lixin; Ran,Jingping; Zhang,Lei; Xiao,Na; Li,Xiaoli

doi:10.3892/etm.2021.10756

Gas6/Axl signaling pathway promotes proliferation, migration and invasion and inhibits apoptosis in A549 cells

Authors:
- Dong Wang
- Lixin Bi
- Jingping Ran
- Lei Zhang
- Na Xiao
- Xiaoli Li
View Affiliations

Affiliations: Department of Tuberculosis, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R. China, Clinical Laboratory, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R. China, Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R. China
Published online on: September 20, 2021 https://doi.org/10.3892/etm.2021.10756
Article Number: 1321

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Several studies have demonstrated that growth arrest‑specific protein 6 (Gas6) and Axl are highly expressed in various tumor tissues, such as renal cell and esophageal carcinoma. However, the effect of the Gas6/Axl signaling pathway on lung adenocarcinoma is still unclear. The aim of the present study was to investigate the effect of the Gas6/Axl signaling pathway on lung adenocarcinoma cells and its mechanism of action, which may provide a novel target for the clinical treatment of lung adenocarcinoma. Human lung adenocarcinoma tissues were used to examine the activation of the Gas6/Axl signaling pathway. In addition, the human lung adenocarcinoma cell line A549 was employed to study the effects of the Gas6/Axl signaling pathway on the proliferation, migration, invasion and apoptosis of lung adenocarcinoma cells. Recombinant human Gas6 protein and inhibitor TP‑0903 were used to activate and inhibit the Gas6/Axl signaling pathway, respectively. The results revealed that Gas6 and Axl expression level was increased in human lung adenocarcinoma tissues compared with adjacent healthy tissues. After inhibition of the Gas6/Axl signaling pathway with TP‑0903, p21, p53, caspase 3, caspase 8 and caspase 9 exhibited higher expression level in A549 cells. The opposite effect was observed when the Gas6/Axl signaling pathway was activated. In addition, the migratory and invasive ability of A549 cells was determined via wound‑healing and Transwell invasion assays. The results indicated that the migratory and invasive ability of A549 cells was significantly increased when the Gas6/Axl signaling pathway was activated and inhibition of Gas6/Axl signaling pathway caused the opposite results. Activity of Gas6/Axl signaling pathway was shown to be positively associated with cell proliferation by Cell Counting Kit 8 and clone formation assays. In conclusion, the Gas6/Axl signaling pathway was revealed to promote the proliferation, migration and invasion and inhibit the apoptosis of lung adenocarcinoma cells, which serve important roles in the progression of lung adenocarcinoma.

View Figures

View References

1	Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR and Feuer EJ: The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 383:640–649. 2020.PubMed/NCBI View Article : Google Scholar
2	Schwartz AG and Cote ML: Epidemiology of lung cancer. Adv Exp Med Biol. 893:21–41. 2016.PubMed/NCBI View Article : Google Scholar
3	Yang F, Li H and Wang J: The precision surgical treatment strategies of lung adenocarcinoma under the guidance of the WHO new classification. Zhonghua Wai Ke Za Zhi. 55:49–53. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
4	Morales-Oyarvide V and Mino-Kenudson M: Tumor islands and spread through air spaces: Distinct patterns of invasion in lung adenocarcinoma. Pathol Int. 66:1–7. 2016.PubMed/NCBI View Article : Google Scholar
5	Kometani T, Sugio K, Osoegawa A, Seto T and Ichinose Y: Clinicopathological features of younger (aged ≤50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene. Thoracic Cancer. 9:563–570. 2018.PubMed/NCBI View Article : Google Scholar
6	Senan S, Paul MA and Lagerwaard FJ: Treatment of early-stage lung cancer detected by screening: Surgery or stereotactic ablative radiotherapy? Lancet Oncol. 14:e270–e274. 2013.PubMed/NCBI View Article : Google Scholar
7	Jiang N and Xu X: Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network. Medicine (Baltimore). 98(e15642)2019.PubMed/NCBI View Article : Google Scholar
8	Chang CH, Lee CH and Wang JY: Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior? J Clin Oncol. 35:1374–1375. 2017.PubMed/NCBI View Article : Google Scholar
9	Gustafsson A, Fritz HKM and Dahlbäck B: Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages. Exp Cell Res. 355:47–56. 2017.PubMed/NCBI View Article : Google Scholar
10	Antony J, Tan TZ, Kelly Z, Low J, Choolani M, Recchi C, Gabra H, Thiery JP and Huang RYJ: The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer. Sci Signal. 9(ra97)2016.PubMed/NCBI View Article : Google Scholar
11	Jin Y, Nie D, Li J, Du X, Lu Y, Li Y, Liu C, Zhou J and Pan J: Gas6/AXL signaling regulates self-renewal of chronic myelogenous leukemia stem cells by stabilizing beta-catenin. Clin Cancer Res. 23:2842–2855. 2017.PubMed/NCBI View Article : Google Scholar
12	Sawabu T, Seno H, Kawashima T, Fukuda A, Uenoyama Y, Kawada M, Kanda N, Sekikawa A, Fukui H, Yanagita M, et al: Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog. 46:155–164. 2007.PubMed/NCBI View Article : Google Scholar
13	Lee HJ, Jeng YM, Chen YL, Chung L and Yuan RH: Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of slug in hepatocellular carcinoma. Carcinogenesis. 35:769–775. 2014.PubMed/NCBI View Article : Google Scholar
14	Sinha S, Boysen J, Nelson M, Secreto C, Warner SL, Bearss DJ, Lesnick C, Shanafelt TD, Kay NE and Ghosh AK: Targeted Axl inhibition primes chronic lymphocytic leukemia B cells to apoptosis and shows synergistic/additive effects in combination with BTK inhibitors. Clin Cancer Res. 21:2115–2126. 2015.PubMed/NCBI View Article : Google Scholar
15	Morizono K, Xie Y, Olafsen T, Lee B, Dasgupta A, Wu AM and Chen IS: The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe. 9:286–298. 2011.PubMed/NCBI View Article : Google Scholar
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
17	Testa U, Castelli G and Pelosi E: . Lung cancers: Molecular characterization, clonal heterogeneity and evolution, and cancer stem cells. Cancers (Basel). 10(248)2018.PubMed/NCBI View Article : Google Scholar
18	Kariolis MS, Miao YR, Diep A, Nash SE, Olcina MM, Jiang D, Jones DS II, Kapur S, Mathews II, Koong AC, et al: Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest. 127:183–198. 2017.PubMed/NCBI View Article : Google Scholar
19	Wang C, Jin H, Wang N, Fan S, Wang Y, Zhang Y, Wei L, Tao X, Gu D, Zhao F, et al: Gas6/Axl axis contributes to chemoresistance and metastasis in breast cancer through Akt/GSK-3β/β-catenin signaling. Theranostics. 6:1205–1219. 2016.PubMed/NCBI View Article : Google Scholar
20	Zhao CC, Chen J, Niu RF, Liu Y and Zhang CG: Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma. Oncol Rep. 40:3392–33404. 2018.PubMed/NCBI View Article : Google Scholar
21	Faget J, Contat C, Zangger N, Peters S and Meylan E: RANKL Signaling sustains primary tumor growth in genetically engineered mouse models of lung adenocarcinoma. J Thorac Oncol. 13:387–398. 2018.PubMed/NCBI View Article : Google Scholar
22	Han J, Tian R, Yong B, Luo C, Tan P, Shen J and Peng T: Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients. Biochem Biophys Res Commun. 435:493–500. 2013.PubMed/NCBI View Article : Google Scholar
23	Rankin EB, Fuh KC, Taylor TE, Krieg AJ, Musser M, Yuan J, Wei K, Kuo CJ, Longacre TA and Giaccia AJ: AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res. 70:7570–7579. 2010.PubMed/NCBI View Article : Google Scholar
24	Sainaghi PP, Castello L, Bergamasco L, Galletti M, Bellosta P and Avanzi GC: Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor. J Cell Physiol. 204:36–44. 2005.PubMed/NCBI View Article : Google Scholar
25	Seike M, Kim CH, Zou F, Noro R, Chiba M, Ishikawa A, Κunugi S, Kubota K and Gemma A: AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier. Oncol Rep. 37:3261–3269. 2017.PubMed/NCBI View Article : Google Scholar
26	Scafoglio CR, Villegas B, Abdelhady G, Bailey ST, Liu J, Shirali AS, Wallace WD, Magyar CE, Grogan TR, Elashoff D, et al: Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. Sci Transl Med. 10(eaat5933)2018.PubMed/NCBI View Article : Google Scholar